Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

L. Fallowfield*, D. Gagnon, M. Zagari, D. Cella, B. Bresnahan, T. J. Littlewood, P. McNulty, G. Gorzegno, M. Freund

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences